Stephan (from Germany) did his PhD at the MPI for Molecular Genetics in Berlin before moving to Melbourne, Australia (The Bio21 Molecular Science and Biotechnology Institute) where he worked on establishing new lipidomics techniques. From there he moved to The Florey Institute of Neuroscience and Mental Health (also in Melbourne) where he was responsible for metabolite and lipid analyses of blood and brain samples from patients with Parkinson’s or Alzheimer’s disease. Stephan has been running the Institute for Vascular Signalling Metabolomics Core since returning to Germany at the start of 2021.